Treatment of Chronic Post-Traumatic Headache With OnabotulinumtoxinA
Status:
Terminated
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
This study will provide evidence on whether the use of an FDA-approved drug therapy for the
treatment of chronic migraine (OnabotulinumtoxinA) shows similar efficacy for treatment of
chronic headaches caused by traumatic injury to the brain (TBI) from a direct hit to the
head, or a fall, or a motor vehicle accident, or some other traumatic event.
Phase:
Phase 3
Details
Lead Sponsor:
University of Washington
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA